Aripiprazole Use in Children Diagnosed with Down Syndrome and Comorbid Autism Spectrum Disorders

Simple item page
dc.contributor.authorBacanli, Ali
dc.contributor.orcIDhttps://orcid.org/0000-0002-9730-7206en_US
dc.contributor.pubmedID26870907en_US
dc.contributor.researcherIDAAJ-8298-2021en_US
dc.date.accessioned2023-07-24T13:16:37Z
dc.date.available2023-07-24T13:16:37Z
dc.date.issued2016
dc.identifier.endpage308en_US
dc.identifier.issn1044-5463en_US
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-84969664315en_US
dc.identifier.startpage306en_US
dc.identifier.urihttp://hdl.handle.net/11727/10078
dc.identifier.volume26en_US
dc.identifier.wos000374838600020en_US
dc.language.isoengen_US
dc.relation.isversionof10.1089/cap.2015.0193en_US
dc.relation.journalJOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectADOLESCENTSen_US
dc.subjectIRRITABILITYen_US
dc.subjectPHARMACOLOGYen_US
dc.subjectSEROTONINen_US
dc.titleAripiprazole Use in Children Diagnosed with Down Syndrome and Comorbid Autism Spectrum Disordersen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine